Novacea, Transcept to reverse-merge

Transcept (Point Richmond, Calif.) and Novacea (NASDAQ:NOVC) agreed to reverse-merge to create Transcept Pharmaceuticals Inc. Transcept stockholders are expected to own 60% of the combined company, and Novacea stockholders are expected to own the remaining 40%. Transcept President and CEO Glenn Oclassen will be head of the newco. ...